Skip to main content

Table 2 Clinical assessments

From: A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol

Clinician-Administered Assessments
 Mini International Neuropsychiatric Interview (MINI)
 Montgomery-Åsberg Depression Rating Scale (MADRS)
 Clinical Global Impression (CGI)
 Young Mania Rating Scale (YMRS)
 Columbia-Suicide Severity Rating Scale (C-SSRS)
 Toronto Side Effects Scale (TSES)
 Montreal Cognitive Assessment (MOCA)
 CNS Vital Signs (CNS-VS), Computerized neurocognitive battery
Self-Report Assessments
 Patient Health Questionnaire (PHQ-9)
 Generalized Anxiety Disorder 7-item scale (GAD-7)
 Quality of Life, Enjoyment and Satisfaction Questionnaire-short form (Q-LESQ-SF)
 Dimensional Anhedonia Rating Scale (DARS)
 Medical Outcome Study - short Form 36 (SF-36)
 Drug Abuse Screening Test (DAST-10)
 Beck Scale for Suicide Ideation (BSS)